[Seite 129↓]

5 Literaturverzeichnis

[1] Starzl, T. E.; Demetris, A. J. und van Thiel, D. (1989): Liver transplantation (First of two parts), New England Journal of Medicine (Band 321), Seite 1014-1022.

[2] (1994): Consensus Conference on Indications of Liver Transplantation. Paris, France, June 22-23, 1993, Hepatology (Band 20), Nr. 1 Pt 2, Seite 1S-68S.

[3] Jonas, S.; Herrmann, M.; Rayes, N.; Berg, T.; Radke, C.; Tullius, S.; Settmacher, U.; Steinmuller, T. und Neuhaus, P. (2001): Survival after liver transplantation for hepatocellular carcinoma in cirrhosis according to the underlying liver disease, Transplantation Proceedings (Band 33), Nr. 7-8, Seite 3444-3445.

[4] Jonas, S.; Bechstein, W. O.; Steinmuller, T.; Herrmann, M.; Radke, C.; Berg, T.; Settmacher, U. und Neuhaus, P. (2001): Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis, Hepatology (Band 33), Nr. 5, Seite 1080-1086.

[5] Mueller, A. R.; Platz, K. P.; Krause, P.; Kahl, A.; Rayes, N.; Glanemann, M.; Lang, M.; Wex, C.; Bechstein, W. O. und Neuhaus, P. (2000): Perioperative factors influencing patient outcome after liver transplantation, Transplant International (Band 13 Suppl 1), Nr. 1997, Seite Chirurgie.

[6] Platz, K. P.; Mueller, A. R.; Spree, E.; Schumacher, G.; Nussler, N. C.; Rayes, N.; Glanemann, M.; Bechstein, W. O. und Neuhaus, P. (2000): Liver transplantation for alcoholic cirrhosis, Transplant International (Band 13 Suppl 1), Nr. 1997, Seite Chirurgie.

[7] Starzl, T. E. und Demetris, A. J. (1990): Liver transplantation: a 31-year perspective. Part II, Curr.Probl.Surg. (Band 27), Nr. 3, Seite 117-178. URL: PM:2406111

[8] Belzer, F. O. und Southard, J. H. (1988): Principles of solid-organ preservation by cold storage, Transplantation (Band 45), Seite 673-676.

[9] Kalayoglu, M.; Stratta, R. J.; Hoffmann, R. M.; Sollinger, H. W.; D'Alessandro, A. M.; Pirsch, J. D. und Belzer, F. O. (1988): Extended preservation of the liver for clinical transplantation, The Lancet (Band March 19), Seite 617-619.

[10] Iwatsuki, S.; Shaw, B. W. und Starzl, T. E. (1985): Five-year survival after liver transplantation, Transplantation Proceedings (Band 17), Seite 259-263.


[Seite 130↓]

[11] Mirza, DF.; Gunson, BK.; DaSilva, RF.; Mayer, AD.; Buckels, AC. und McMasters, P. (1994): Policies in Europe on "marginal quality" donor livers., Lancet. (Band 344), Seite 1480-1483.

[12] Everhart, J. E.; Lombardero, M.; Detre, K. M.; Zetterman, R. K.; Wiesner, R. H.; Lake, J. R. und Hoofnagle, J. H. (1997): Increased waiting time for liver transplantation results in higher mortality., Transplantation (Band 64), Nr. 9, Seite 1300-1306. URL: PMID: 9371672, UI: 98037723

[13] Ploeg, R. J.; D'Alessandro, A. M.; Knechtle, S. J.; Stegall, M. D.; Pirsch, J. D.; Hoffmann, R. M.; Sasaki, T.; Sollinger, H. W.; Belzer, F. O. und Kalayoglu, M. (1993): Risk factors for primary dysfunction after liver transplantation--A multivariate analysis, Transplantation (Band 55), Seite 807-813.

[14] Todo, S.; Demetris, A. J.; Makowa, L.; Teperman, L.; Shaver, T.; Tzakis, A. und Starzl, T. E. (1989): Primary nonfunction of hepatic allografts with preexisting fatty infiltration, Transplantation (Band 47), Nr. 5, Seite 903-905.

[15] Markmann, J. F.; Markmann, J. W.; Markmann, D. A.; Bacquerizo, A.; Singer, J.; Holt, C. D.; Gornbein, J.; Yersiz, H.; Morrissey, M.; Lerner, S. M.; McDiarmid, S. V. und Busuttil, R. W. (2001): Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants, Transplantation (Band 72), Nr. 6, Seite 1113-1122.

[16] Markin, R. S.; Wisecarver, J. L.; Radio, S. J.; Stratta, R. J.; Langnas, A. N.; Hirst, K. und Shaw, B. W. (1993): Frozen section evaluation of donor livers before transplantation., Transplantation (Band 56), Seite 1403-1409.

[17] Hilden, M.; Christoffersen, P.; Juhl, E. und Dalgaard, J. B. (1977): Liver histology in a 'normal' population - Examinations of 503 consecutive fatal traffic accidents, Scand J Gastrorent (Band 12), Seite 593-597.

[18] Strasberg, S. M.; Howard, T. K.; Molmenti, E. P. und Hertl, M. (1994): Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation, Hepatology (Band 20), Nr. 4, Seite 829-838.

[19] Pruim, J.; Klompmaker, I. J.; Haagsma, E. B.; Bijleveld, C. M. und Slooff, M. J. H. (1993): Selection criteria for liver donation: a review, Transplant International (Band 6), Seite 226-235.


[Seite 131↓]

[20] Broelsch, C. E.; Emond, J. C.; Thistlethwaite, J. R.; Rouch, D. A.; Whitington, P. F. und Lichtor, J. L. (1988): Liver transplantation with reduced-size donor organs, Transplantation (Band 45), Seite 519-524.

[21] Emond, J. C.; Whitington, P. F.; Thistlethwaite, J. R.; Cherqui, D.; Alonso, E. A.; Woodle, I. S.; Vogelbach, P.; Busse-Henry, S. M.; Zucker, A. R. und Broelsch, C. E. (1990): Transplantation of two patients with one liver. Analysis of a preliminary experience with `split-liver' grafting, Annals of Surgery (Band 212), Seite 14-22.

[22] Grewal, H. P.; Thistlewaite, J. R., Jr.; Loss, G. E.; Fisher, J. S.; Cronin, D. C.; Siegel, C. T.; Newell, K. A.; Bruce, D. S.; Woodle, E. S.; Brady, L.; Kelly, S.; Boone, P.; Oswald, K. und Millis, J. M. (1998): Complications in 100 living-liver donors, Ann Surg (Band 228), Nr. 2, Seite 214-219. URL: PM:0009712567

[23] Malago, M.; Burdelski, M. und Broelsch, C. E. (1999): Present and future challenges in living related liver transplantation, Transplant Proc (Band 31), Nr. 4, Seite 1777-1781. URL: PM:0010371950

[24] Marcos, A. (2000): Right-lobe living donor liver transplantation, Liver Transpl. (Band 6), Nr. 6 Suppl 2, Seite S59-S63.

[25] Marcos, A.; Fisher, R. A.; Ham, J. M.; Olzinski, A. T.; Shiffman, M. L.; Sanyal, A. J.; Luketic, V. A.; Sterling, R. K.; Olbrisch, M. E. und Posner, M. P. (2000): Selection and outcome of living donors for adult to adult right lobe transplantation, Transplantation (Band 69), Nr. 11, Seite 2410-2415.

[26] Renz, J. F. und Busuttil, R. W. (2000): Adult-to-adult living-donor liver transplantation: a critical analysis, Semin.Liver Dis. (Band 20), Nr. 4, Seite 411-424.

[27] Broering, D. C.; Topp, S.; Schaefer, U.; Fischer, L.; Gundlach, M.; Sterneck, M.; Schoder, V.; Pothmann, W. und Rogiers, X. (2002): Split liver transplantation and risk to the adult recipient: analysis using matched pairs, J.Am.Coll.Surg. (Band 195), Nr. 5, Seite 648-657.

[28] Kiuchi, T.; Inomata, Y.; Uemoto, S.; Asonuma, K.; Egawa, H.; Fujita, S.; Hayashi, M.; Uryuhara, K. und Tanaka, K. (2000): Evolution of living donor liver transplantation in adults: a single center experience, Transplant International (Band 13 Suppl 1), Nr. 1997, Seite Chirurgie.

[29] Fujita, S.; Kim, I. D.; Uryuhara, K.; Asonuma, K.; Egawa, H.; Kiuchi, T.; Hayashi, M.; Uemeto, S.; Inomata, Y. und Tanaka, K. (2000): Hepatic grafts from live donors: donor morbidity for 470 cases of live donation, Transplant International (Band 13), Nr. 5, Seite 333-339.


[Seite 132↓]

[30] Beavers, K. L.; Sandler, R. S. und Shrestha, R. (2002): Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review, Liver Transpl. (Band 8), Nr. 2, Seite 110-117.

[31] Beavers, K. L.; Sandler, R. S.; Fair, J. H.; Johnson, M. W. und Shrestha, R. (2001): The living donor experience: donor health assessment and outcomes after living donor liver transplantation, Liver Transpl. (Band 7), Nr. 11, Seite 943-947.

[32] Renz, J. F. und Roberts, J. P. (2000): Long-term complications of living donor liver transplantation, Liver Transpl. (Band 6), Nr. 6 Suppl 2, Seite S73-S76.

[33] Alexander, J. W. und Vaughn, W. K. (1991): The use of "marginal" donors for organ transplantation, Transplantation (Band 51), Nr. 1, Seite 135-141.

[34] D'Alessandro, A. M.; Kalayoglu, M.; Sollinger, H. W.; Hoffmann, R. M.; Reed, A.; Knechtle, S. J.; Pirsch, J. D.; Hafez, G. R.; Lorentzen, D. und Belzer, F. O. (1991): The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation, Transplantation (Band 51), Seite 157-163.

[35] De Charlis, L.; Sansalone, C. V.; Rondinara, G. F.; Slim, O. A.; Aseni, P.; Rossetti, O.; Colella, G.; Della Volpe, A.; and Forti, D. (1995): Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria

[36] Hassanein, T. I.; Gavaler, J. S.; Fishkin, D.; Gordon, R.; Starzl, T. E. und Van Thiel, D. H. (1991): Does the presence of a measurable blood alcohol level in a potential organ donor affect the outcome of liver transplantation?, Alcoholism, Clinical and Experimental Research (Band 15), Seite 300-303.

[37] Makowka, L.; Gordon, R. D.; Todo, S.; Ohkohchi, N.; Marsh, J. W.; Tzakis, A. G.; Yokoi, H.; Ligush, J.; Esquivel, C. O.; Satake, M.; Iwatsuki, S. und Starzl, T. E. (1987): Analysis of donor criteria for the prediction of outcome in clinical liver transplantation., Transplantation Proceedings (Band 19), Nr. 1, Seite 2378-2382.

[38] Marsman, W. A.; Wiesner, R. H.; Rodrigues, L.; Batts, K. P.; Porayko, M. K.; Hay, J. E.; Gores, G. J. und Krom, R. A. F. (1997): Use of fatty donor liver is associated with diminished early patient and graft survival, Transplantation (Band 62), Nr. 9, Seite 1246-1251.


[Seite 133↓]

[39] Nagano, H. und Tilney, N. L. (1997): Chronic allograft failure: the clinical problem, Am.J Med Sci (Band 313), Nr. 5, Seite 305-309.

[40] Quiroga, J.; Colina, I.; Demetris, A. J.; Starlz, T. E. und Van Thiel, D. H. (1991): Cause and timing of first allograft failure in orthotopic liver transplantation: A study of 177 consecutive patients, Hepatology (Band 14), Seite 1054-1062.

[41] Greig, P. D.; Woolf, G. M.; Sinclair, S. B.; Abecassis, M.; Strasberg, S. M.; Taylor, B. R.; Blendis, L. M.; Superina, R. A.; Glynn, M. F. X.; Langer, B. und Levy, G. A. (1989): Treatment of primary liver graft nonfunction with prostaglandin E1, Transplantation (Band 48), Seite 447-453.

[42] Gao, W.; Connor, H. D.; Lemasters, J. J.; Mason, R. P. und Thurman, R. G. (1995): Primary nonfunction of fatty livers produced by alcohol is associated with a new, antioxidant-insensitive free radical species, Transplantation (Band 59), Seite 674-679.

[43] Todo, S.; Demetris, A. J.; Makowka, L.; Tepperman, L.; Podesta, L.; Shaver, T.; Tzakis, A. und Starzl, T. E. (1989): Primary nonfunction of hepatic allografts with preexisting fatty infiltration, Transplantation (Band 47), Seite 903-905.

[44] Momii, S. und Koga, A. (1990): Time-related morphological changes in cold-stored rat livers. A comparison of Euro-Collins solution with UW solution, Transplantation (Band 50), Nr. 5, Seite 745-750.

[45] Erhard, J.; Lange, R.; Scherer, R.; Kox, W. J.; Bretschneider, H. J.; Gebhard, M. M. und Eigler, F. W. (1994): Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. A prospective, randomized study, Transplant International (Band 7), Nr. 3, Seite 177-181.

[46] McKeown, C. M. B.; Edwards, V.; Phillips, M. J.; Harvey, P. R. C.; Petrunka, C. N. und Strasberg, S. M. (1988): Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat, Transplantation (Band 46), Seite 178-191.

[47] Caldwell-Kenkel, J. C.; Currin, R. T.; Tanaka, Y.; Thurman, R. G. und Lemasters, J. J. (1989): Reperfusion injury to endothelial cells following cold ischemic storage of rat liver, Hepatology (Band 10), Seite 292-299.

[48] Caldwell-Kenkel, J. C.; Thurman, R. G. und Lemasters, J. J. (1988): Selective loss of nonparenchymal cell viability after cold ischemic storage of rat livers, Transplantation (Band 45), Seite 834-837.


[Seite 140↓]

[49] Takei, Y.; Marzi, I.; Gao, W.; Gores, G. J.; Lemasters, J. J. und Thurman, R. G. (1991): Leukocyte adhesion and cell death following orthotopic liver transplantation in the rat, Transplantation (Band 51), Seite 959-965.

[50] Clavien, P. A.; Morgan, G.; Sanabria, J. R.; Harvey, P. R. C. und Strasberg, S. M. (1991): Effect of cold preservation on lymphocyte adherence in the perfused rat liver., Transplantation (Band 52), Seite 412-417.

[51] Marzi, I.; Knee, J.; Menger, M. D.; Harbauer, G. und Buhren, V. (1991): Hepatic microcirculatory disturbances due to portal vein clamping in the orthotopic rat liver transplantation model, Transplantation (Band 52), Seite 432-436.

[52] Holloway, C. M. B.; Harvey, P. R. C. und Strasberg, S. M. (1990): Viability of sinusoidal lining cells in cold-preserved rat liver allografts, Transplantation (Band 49), Seite 225-229.

[53] Gao, W.; Bentley, R. C.; Madden, J. F. und Clavien, P. A. (1998): Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation., Hepatology (Band 27), Nr. 6, Seite 1652-1660.

[54] Sindram, D.; Porte, R. J.; Hoffman, M. R.; Bentley, R. C. und Clavien, P. A. (2000): Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver, Gastroenterology (Band 118), Nr. 1, Seite 183-191.

[55] Marzi, I.; Zhong, Z.; Lemasters, J. J. und Thurman, R. G. (1989): Evidence that graft survival is not related to parenchymal cell viability in rat liver transplantation, Transplantation (Band 48), Seite 463-468.

[56] Thurman, R. G.; Bunzendahl, H. und Lemasters, J. J. (1993): Role of sinusoidal lining cells in hepatic reperfusion injury following cold storage and transplantation, Seminars in Liver Disease (Band 13), Seite 93-100.

[57] Connor, H. D.; Gao, W.; Nukina, S.; Lemasters, J. J.; Mason, R. P. und Thurman, R. G. (1992): Evidence that free radicals are involved in graft failure following orthotopic liver transplantation in the rat -- An electron paramagnetic resonance spin trapping study, Transplantation (Band 54), Seite 199-204.

[58] Jaeschke, H. und Farhood, A. (1991): Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver., American Journal of Physiology (Band 260), Seite G355-G362.


[Seite 135↓]

[59] Jaeschke, H.; Bautista, A. P.; Spolarics, Z. und Spitzer, J. J. (1991): Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia, Free Radical Research Communications (Band 15), Seite 277-284.

[60] Jaeschke, H.; Bautista, A. P.; Spolarics, Z. und Spitzer, J. J. (1992): Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats, J.Leukoc.Biol. (Band 52), Seite 377-382.

[61] Bulkley, G. B. (1983): The role of oxygen free radicals in human disease processes, Surgery (Band 94), Seite 407-411.

[62] Bremer, C.; Bradford, B. U.; Hunt, K. J.; Knecht, K. T.; Connor, H. D.; Mason, R. P. und Thurman, R. G. (1994): Role of Kupffer cells in the pathogenesis of hepatic reperfusion injury, American Journal of Physiology (Band 267), Seite G630-G636.

[63] Persson, J. O.; Terelius, Y. und Ingelman-Sundberg, M. (1990): Cytochrome P450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P450-mediated reduction of oxygen and carbon tetrachloride, Xenobiotica (Band 20), Seite 887-900.

[64] Zhong, Z.; Lemasters, J. J. und Thurman, R. G. (1989): Role of purines and xanthine oxidase in reperfusion injury in perfused rat liver, Journal of Pharmacology and Experimental Therapeutics (Band 250), Seite 470-475.

[65] Friedl, H. P.; Till, G. O.; Ryan, U. S. und Ward, P. A. (1989): Mediator-induced activation of xanthine oxidase in endothelial cells, FASEB Journal (Band 3), Seite 2512-2518.

[66] Brass, C. A.; Narciso, J. und Gollan, J. L. (1991): Enhanced activity of the free radical producing enzyme xanthine oxidase in hypoxic rat liver, The Journal of Clinical Investigation (Band 87), Seite 424-431.

[67] Arroyo, C. M.; Kramer, J. H.; Leiboff, R. H.; Mergner, G. W.; Dickens, B. F. und Weglicki, W. B. (1987): Spin trapping of oxygen and carbon-centered free radicals in ischemic canine myocardium, Free Radicals Biolology and Medicine (Band 3), Seite 313-316.

[68] Arroyo, C. M.; Kramer, J. H.; Dickens, B. F. und Weglicki, W. B. (1987): Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO, FEBS Letters (Band 221(1)), Seite 101-104.


[Seite 136↓]

[69] Kramer, J. H.; Arroyo, C. M.; Dickens, B. F. und Weglicki, W. B. (1987): Spin-trapping evidence that graded myocardial ischemia alters post-ischemic superoxide production, Free Rad.Biol.& Med. (Band 3), Seite 153-159.

[70] Bachmann, S.; Caldwell-Kenkel, J. C.; Thurman, R. G.; and Lemasters, J. J. (1991): Pentoxyfylline and Carolina Rinse solution prevent graft failure from storage injury after orthotopic rat liver transplantation with rearterialization

[71] Gao, W.; Takei, Y.; Marzi, I.; Lindert, K. A.; Caldwell-Kenkel, J. C.; Currin, R. T.; Tanaka, Y.; Lemasters, J. J. und Thurman, R. G. (1991): Carolina Rinse solution: A new strategy to increase survival time after orthotopic liver transplantation in the rat, Transplantation (Band 52), Seite 417-424.

[72] Clavien, P. A.; Harvey, P. R. C. und Strasberg, S. M. (1992): Preservation and perfusion injury in liver allografts., Transplantation (Band 53), Seite 957-978.

[73] Takei, Y.; Marzi, I.; Gao, W.; Gores, G. G.; Lemasters, J. J. und Thurman, R. G. (1991): Leukocyte adhesion and cell death following orthotopic liver transplantation in the rat, Transplantation (Band 51), Seite 959-965.

[74] Koeppel, T. A.; Lehmann, T. G.; Thies, J. C.; Gehrcke, R.; Gebhard, M. M.; Herfarth, C.; Otto, G. und Post, S. (1996): Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation., Transplantation (Band 61), Nr. 9, Seite 1397-1409.

[75] Takei, Y.; Marzi, I.; Kauffman, F. C.; Lemasters, J. J. und Thurman, R. G. (1990): Increase in survival time of liver transplants from injury by protease inhibitors and a calcium channel blocker, nisoldipine., Transplantation (Band 50), Seite 14-20.

[76] Gao, W.; Hijioka, T.; Lindert, K. A.; Caldwell-Kenkel, J. C.; Lemasters, J. J. und Thurman, R. G. (1991): Evidence that adenosine is a key component in Carolina Rinse responsible for reducing graft failure after orthotopic liver transplantation in the rat, Transplantation (Band 52), Seite 992-998.

[77] Currin, R. T.; Toole, J. G.; Thurman, R. G. und Lemasters, J. J. (1990): Evidence that Carolina rinse solution protects sinusoidal endothelial cells against reperfusion injury after cold ischemic storage of rat liver, Transplantation (Band 50), Seite 1076-1078.

[78] Sanchez-Urdazpal, L.; Gores, G. J.; Lemasters, J. J.; Thurman, R. G.; Steers, J. L.; Wahlstrom, H. E.; Hay, E. I.; Porayko, M. K.; Wiesner, R. H. und Krom, R. A. F. (1993): Carolina Rinse solution decreases liver injury during clinical liver transplantation, Transplantation Proceedings (Band 25), Seite 1574-1575.


[Seite 137↓]

[79] Vollmar, B.; Menger, M. D.; Glasz, J.; Leiderer, R. und Messmer, K. (1994): Impact of leukocyte-endothelial cell interaction in hepaticischemia-reperfusion injury, American Journal of Physiology (Band 267), Nr. 5 Pt 1, Seite G786-G793.

[80] Hernandez, L. A.; Grisham, M. B.; Twohig, B.; Arfors, K. E.; Harlan, J. M. und Granger, D. N. (1987): Role of neutrophils in ischemia-reperfusion-induced microvascular injury, American Journal of Physiology (Band 253), Seite H699-H703.

[81] Hamamoto, I.; Nemoto, E. M.; Shimin, Z. und Todo, S. (1993): Severe tissue damage occurs during cold preservation of liver grafts, Transplantation Proceedings (Band 25), Nr. 6, Seite 3228-3229. URL: PM:8266524

[82] Von Andrian, U. H.; Hansell, P.; Chambers, J. D.; Berger, E. M.; Torres, Filho, I; Butcher, E. C. und Arfors, K. E. (1992): L-selectin function is required for beta 2-integrin-mediated neutrophil adhesion at physiological shear rates in vivo, American Journal of Physiology (Band 263), Nr. 4 Pt 2, Seite H1034-H1044. URL: PM:0001384360

[83] Steinhoff, G.; Behrend, M.; Schrader, B. und Pichlamyr, R. (1993): Intercellular adhesion molecules in human liver transplants: overview and expression patterns of leukocyte receptor and ligand molecules., Hepatology (Band 18), Seite 440-453.

[84] Fusaoka, T.; Hunt, K. J.; Lemasters, J. J. und Thurman, R. G. (1994): Evidence that activation of Kupffer cells increases oxygen uptake after cold storage, Transplantation (Band 58), Seite 1067-1071.

[85] Thurman, R. G.; Marzi, I.; Seitz, G.; Thies, J.; Lemasters, J. J. und Zimmermann, F. A. (1988): Hepatic reperfusion injury following orthotopic liver transplantation in the rat, Transplantation (Band 46), Seite 502-506.

[86] Teramoto, K.; Bowers, J. L.; Kruskal, J. B. und Clouse, M. E. (1993): Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat, Transplantation (Band 56), Seite 1076-1082.

[87] Adam, R.; Reynes, M.; Johann, M.; Morino, M.; Astacioglu, I.; Kafetzis, I.; Castaing, D. und Bismuth, H. (1991): The outcome of steatotic grafts in liver transplantation, Transplantation Proceedings (Band 23), Seite 1538-1540.

[88] Knecht, K. T.; Adachi, Y.; and Thurman, R. G. (1993): Detection of free radical adducts in the bile of rats treated chronically with intragastric alcohol


[Seite 138↓]

[89] Adachi, Y.; Moore, L. E.; Bradford, B. U.; Gao, W. und Thurman, R. G. (1995): Antibiotics prevent liver injury in rats following long-term exposure to ethanol, Gastroenterology (Band 108), Seite 218-224.

[90] Adachi, Y.; Bradford, B. U.; Gao, W.; Bojes, H. K. und Thurman, R. G. (1994): Inactivation of Kupffer cells prevents early alcohol-induced liver injury, Hepatology (Band 20), Seite 453-460.

[91] Arteel, G. E.; Iimuro, Y.; Yin, M.; Raleigh, J. A. und Thurman, R. G. (1997): Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo., Hepatology (Band 25), Nr. 4, Seite 920-926.

[92] Ji, S.; Lemasters, J. J.; Christenson, V. R. und Thurman, R. G. (1982): Periportal and pericentral pyridine nucleotide fluorescence from the surface of the perfused liver: Evaluation of the hypothesis that chronic treatment with ethanol produces pericentral hypoxia, Proceedings of the National Academy of Sciences of the United States of America (Band 79), Seite 5415-5419.

[93] Thurman, R. G.; Gao, W.; Connor, H. D.; Adachi, Y.; Stachlewitz, R. F.; Zhong, Z.; Knecht, K. T.; Bradford, B. U.; Mason, R. P. und Lemasters, J. J. (1995): Role of Kupffer cells in failure of fatty livers following liver transplantation and alcoholic liver injury, J.Gastroenterol.Hepatol. (Band 10 Suppl 1:S24-30), Seite S24-30.

[94] D'Alessandro, A. M.; Kalayoglu, M.; Sollinger, H. W.; Hoffman, R. M.; Reed, A.; Knechtle, S. J.; Pirsch, J. D.; Hafez, G. R.; Lerentzen, D. und Belzer, F. O. (1991): The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation., Transplantation (Band 51), Seite 157-163.

[95] Taneja, C.; Prescott, L. und Koneru, B. (1998): Critical preservation injury in rat fatty liver is to hepatocytes, not sinusoidal lining cells, Transplantation (Band 65), Nr. 2, Seite 167-172.

[96] Belghiti, J.; Noun, R.; Malafosse, R.; Jagot, P.; Sauvanet, A.; Pierangeli, F.; Marty, J. und Farges, O. (1999): Continuous versus intermittent portal triad clamping for liver resection: a controlled study, Annals of Surgery (Band 229), Nr. 3, Seite 369-375.

[97] Peralta, C.; Hotter, G.; Closa, D.; Gelpi, E.; Bulbena, O. und Rosello-Catafau, J. (1997): Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine, Hepatology (Band 25), Nr. 4, Seite 934-937.


[Seite 139↓]

[98] Clavien, P. A.; Yadav, S.; Sindram, D. und Bentley, R. C. (2000): Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans, Annals of Surgery (Band 232), Nr. 2, Seite 155-162.

[99] Peralta, C.; Bulbena, O.; Xaus, C.; Prats, N.; Cutrin, J. C.; Poli, G.; Gelpi, E. und Rosello-Catafau, J. (2002): Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion, Transplantation (Band 73), Nr. 8, Seite 1203-1211.

[100] Peralta, C.; Hotter, G.; Closa, D.; Prats, N.; Xaus, C.; Gelpi, E. und Rosello-Catafau, J. (1999): The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors, Hepatology (Band 29), Nr. 1, Seite 126-132.

[101] Redaelli, C. A.; Tian, Y. H.; Schaffner, T.; Ledermann, M.; Baer, H. U. und Dufour, J. F. (2002): Extended preservation of rat liver graft by induction of heme oxygenase-1, Hepatology (Band 35), Nr. 5, Seite 1082-1092.

[102] Peralta, C.; Bartrons, R.; Riera, L.; Manzano, A.; Xaus, C.; Gelpi, E. und Rosello-Catafau, J. (2000): Hepatic preconditioning preserves energy metabolism during sustained ischemia, Am.J.Physiol Gastrointest.Liver Physiol (Band 279), Nr. 1, Seite G163-G171.

[103] Rudiger, H. A.; Kang, K. J.; Sindram, D.; Riehle, H. M. und Clavien, P. A. (2002): Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver, Annals of Surgery (Band 235), Nr. 3, Seite 400-407.

[104] Columbano, A. (1995): Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo., J.Cell.Biochem. (Band 58), Seite 181-190.

[105] Clavien, P. A.; Rudiger, H. A. und Selzner, M. (2001): Mechanism of hepatocyte death after ischemia: apoptosis versus necrosis, Hepatology (Band 33), Nr. 6, Seite 1555-1557.

[106] Ichijo, H. (1999): From receptors to stress-activated MAP kinases, Oncogene (Band 18), Nr. 45, Seite 6087-6093. URL: PM:0010557099

[107] Carini, R.; De Cesaris, M. G.; Splendore, R.; Vay, D.; Domenicotti, C.; Nitti, M. P.; Paola, D.; Pronzato, M. A. und Albano, E. (2001): Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes, Hepatology (Band 33), Nr. 1, Seite 131-139.


[Seite 140↓]

[108] Schon, M. R.; Kollmar, O.; Wolf, S.; Schrem, H.; Matthes, M.; Akkoc, N.; Schnoy, N. C. und Neuhaus, P. (2001): Liver transplantation after organ preservation with normothermic extracorporeal perfusion, Annals of Surgery (Band 233), Nr. 1, Seite 114-123.

[109] Butler, A. J.; Rees, M. A.; Wight, D. G.; Casey, N. D.; Alexander, G.; White, D. J. und Friend, P. J. (2002): Successful extracorporeal porcine liver perfusion for 72 hr, Transplantation (Band 73), Nr. 8, Seite 1212-1218.

[110] Matsumoto, K.; Honda, K. und Kobayashi, N. (2001): Protective effect of heat preconditioning of rat liver graft resulting in improved transplant survival, Transplantation (Band 71), Nr. 7, Seite 862-868.

[111] Schlesinger, M. J. (1990): Heat shock proteins, The Journal of Biological Chemistry (Band 265), Nr. 21, Seite 12111-12114.

[112] Kume, M.; Yamamoto, Y.; Saad, S.; Gomi, T.; Kimoto, S.; Shimabukuro, T.; Yagi, T.; Nakagami, M.; Takada, Y.; Morimoto, T. und Yamaoka, Y. (1996): Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury, J.Lab Clin.Med (Band 128), Nr. 3, Seite 251-258.

[113] Jaeschke, H. (1995): Mechanisms of oxidative stress-induced acute tissue injury, P.S.E.B.M. (Band 209), Seite 104-111.

[114] Jaeschke, H.; Farhood, A. und Smith, C. W. (1990): Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo, FASEB Journal (Band 4), Seite 3355-3359.

[115] Jaeschke, H. und Mitchell, J. R. (1989): Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury, Biochemical and Biophysical Research Communications (Band 160), Seite 140-147.

[116] Richter, C.; Park, J. W. und Ames, B. N. (1988): Normal oxidative damage to mitochondrial and nuclear DNA is extensive, Proc Natl Acad Sci USA (Band 85), Seite 6465-6467.

[117] Omar, R.; Nomikos, I.; Piccorelli, G.; Savino, J. und Agarwal, N. (1989): Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation, Gut (Band 30), Seite 510-514.

[118] Rauen, U.; Polzar, B.; Stephan, H.; Mannherz, H. G. und De Groot, H. (1999): Cold-induced apoptosis in cultured hepatocytes and liver endothelial cells: mediation by reactive oxygen species, FASEB Journal (Band 13), Nr. 1, Seite 155-168.


[Seite 141↓]

[119] Lander, H. M. (1997): An essential role for free radicals and derived species in signal transduction, FASEB Journal (Band 11), Seite 118-124.

[120] Cohen, G. M. (1997): Caspases: the executioners of apoptosis, Biochemical Journal (Band 326), Nr. Pt 1, Seite 1-16.

[121] Currin, R. T; Caldwell-Kenkel, J. C.; Lichtman, S. N.; Bachmann, S.; Takei, Y.; Kawano, S.; Thurman, R. G. und Lemasters, J. J. (1996): Protection by Carolina rinse solution, acidotic pH, and glycine against lethal reperfusion injury to sinusoidal endothelial cells of rat livers stored for transplantation, Transplantation (Band 62), Nr. 11, Seite 1549-1558.

[122] Gao, W.; Lemasters, J. J. und Thurman, R. G. (1992): The second generation of Carolina Rinse, Solution II, improves graft survival following orthotopic liver transplantation in the rat by preventing reperfusion injury, Transplant International (Band 5), Seite S362-S365.

[123] Bachmann, S.; Caldwell-Kenkel, J. C.; Oleksy, I.; Steffen, R.; Thurman, R. G. und Lemasters, J. J. (1992): Warm Carolina Rinse solution prevents graft failure from storage injury after orthotopic rat liver transplantation with arterialization, Transplant International (Band 5), Seite 108-114.

[124] Bachmann, S.; Bechstein, W. O.; Keck, H.; Lemmens, H. P.; Brandes, N.; John, A. K.; Lemasters, J. J. und Neuhaus, P. (1997): Pilot study: Carolina rinse solution improves graft function after orthotopic liver transplantation in humans., Transplantation Proceedings (Band 29), Nr. 1/2, Seite 390-392.

[125] Strieter, R. M.; Remick, D. G.; Ward, P. A.; Spengler, R. N.; Lynch, J. P.; Larrick, J. und Kunkel, S. L. (1988): Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline, Biochemical and Biophysical Research Communications (Band 155), Seite 1230-1236.

[126]Currin, R. T.; Lichtman, S. N.; Thurman, R. G.; and Lemasters, J. J. (1991): Pentoxifylline, adenosine, prostaglandin E1 and nisoldipine inhibit tumor necrosis factor release from LPS-stimulated rat Kupffer cells

[127] Peng, X. X.; Currin, R. T.; Thurman, R. G. und Lemasters, J. J. (1995): Protection by pentoxifylline against normothermic liver ischemia/reperfusion in rats, Transplantation (Band 59), Nr. 11, Seite 1537-1541.

[128] Ward, A. und Clissold, S. P. (1987): Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy, Drugs (Band 34), Nr. 1, Seite 50-97.


[Seite 142↓]

[129] Husberg, B. S.; Genyk, Y. S. und Klintmalm, G. B. (1994): A new rat model for studies of the ischemic injury after transplantation of fatty livers: improvment after postoperative administration of prostaglandin., Transplantation (Band 57), Nr. 457, Seite 458.

[130] Cattral, M. S.; Altraif, I.; Greig, P. D.; Blendis, L. und Levy, G. A. (1994): Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease, Am.J Med (Band 97), Nr. 4, Seite 369-373.

[131] Flaherty, J. T.; Pitt, B.; Gruber, J. W.; Heuser, R. R.; Rothbaum, D. A.; Burwell, L. R.; George, B. S.; Kereiakes, D. J.; Deitchman, D. und Gustafson, N. (1994): Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction, Circulation (Band 89), Nr. 5, Seite 1982-1991. URL: PM:0008181121

[132] Hatori, N.; Sjoquist, P. O.; Marklund, S. L.; Pehrsson, S. K. und Ryden, L. (1992): Effects of recombinant human extracellular-superoxide dismutase type C on myocardial reperfusion injury in isolated cold-arrested rat hearts, Free Radicals Biolology and Medicine (Band 13), Nr. 2, Seite 137-142. URL: PM:0001516840

[133] Heberer, M.; Jorgensen, J.; Mihatsch, M. J.; Marx, A. und Landmann, J. (1991): Protective effect of allopurinol and superoxide dismutase in renal isografts in cyclosporin A-treated rats, Ren Fail. (Band 13), Nr. 4, Seite 233-242. URL: PM:0001780491

[134] Kondo, S.; Segawa, T.; Tanaka, K.; Izawa, K.; Hashida, M. und Kanematsu, T. (1996): Mannosylated superoxide dismutase inhibits hepatic reperfusion injury in rats, Journal of Surgical Research (Band 60), Nr. 1, Seite 36-40.

[135] Marzi, I.; Knee, J.; Buhren, V.; Menger, M. und Trentz, O. (1992): Reduction by superoxide dismutase of leukocyte-endothelial adherence after liver transplantation, Surgery (Band 111), Nr. 1, Seite 90-97.

[136] Pollak, R.; Andrisevic, J. H.; Maddux, M. S.; Gruber, S. A. und Paller, M. S. (1993): A randomized double-blind trial of the use of human recombinant superoxide dismutase in renal transplantation, Transplantation (Band 55), Nr. 1, Seite 57-60. URL: PM:0008420065

[137] Land, W. und Zweler, J. L. (1997): Prevention of reperfusion-induced, free radical-mediated acute endothelial injury by superoxide dismutase as an effective tool to delay/prevent chronic renal allograft failure: a review., Transplant Proc (Band 29), Nr. 6, Seite 2567-2568.


[Seite 143↓]

[138] Jaeschke, H.; Smith, C. W.; Clemens, M. G.; Ganey, P. E. und Roth, R. A. (1996): Mechanisms of inflammation liver injury: Adhesion molecules and cytotoxicity of neutrophils, Toxicology and applied pharmacology (Band 139), Seite 213-226.

[139] Karlsson, K.; Sandstrom, J.; Edlund, A.; Edlund, T. und Marklund, S. L. (1993): Pharmacokinetics of extracellular-superoxide dismutase in the vascular system, Free Radicals Biolology and Medicine (Band 14), Nr. 2, Seite 185-190. URL: PM:0008381106

[140] Mizoe, A.; Kondo, S.; Azuma, T.; Fujioka, H.; Tanaka, K.; Hashida, M. und Kanematsu, T. (1997): Preventive effects of superoxide dismutase derivatives modified with monosaccharides on reperfusion injury in rat liver transplantation., Journal of Surgical Research (Band 73), Nr. 2, Seite 160-165.

[141] Mizoe, A.; Kondo, S.; Azuma, T.; Fujioka, H.; Tanaka, K.; Hashida, M. und Kanematsu, T. (1997): Preventive effects of superoxide dismutase derivatives modified with monosaccharides on reperfusion injury in rat liver transplantation, Journal of Surgical Research (Band 73), Nr. 2, Seite 160-165.

[142] Cavazzana-Calvo, M.; Hacein-Bey, S.; Saint-Basile, G.; Gross, F.; Yvon, E.; Nusbaum, P.; Selz, F.; Hue, C.; Certain, S.; Casanova, J. L.; Bousso, P.; Deist, F. L. und Fischer, A. (2000): Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease, Scienc (Band 288), Nr. 5466, Seite 669-672.

[143] Check, E. (2002): A tragic setback, Nature (Band 420), Nr. 6912, Seite 116-118.

[144] Check, E. (2002): Regulators split on gene therapy as patient shows signs of cancer, Nature (Band 419), Nr. 6907, Seite 545-546.

[145] Raper, S. E.; Yudkoff, M.; Chirmule, N.; Gao, G. P.; Nunes, F.; Haskal, Z. J.; Furth, E. E.; Propert, K. J.; Robinson, M. B.; Magosin, S.; Simoes, H.; Speicher, L.; Hughes, J.; Tazelaar, J.; Wivel, N. A.; Wilson, J. M. und Batshaw, M. L. (2002): A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency, Hum.Gene Ther (Band 13), Nr. 1, Seite 163-175.

[146] Eck, S. L.; Alavi, J. B.; Judy, K.; Phillips, P.; Alavi, A.; Hackney, D.; Cross, P.; Hughes, J.; Gao, G.; Wilson, J. M. und Propert, K. (2001): Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trial, Hum.Gene Ther (Band 12), Nr. 1, Seite 97-113.


[Seite 144↓]

[147] Elshami, A. A.; Kucharczuk, J. C.; Sterman, D. H.; Smythe, W. R.; Hwang, H. C.; Amin, K. M.; Litzky, L. A.; Albelda, S. M. und Kaiser, L. R. (1995): The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene, Annals of Surgery (Band 222), Nr. 3, Seite 298-307. URL: PM:0007677460

[148] Gleich, L. L.; Gluckman, J. L.; Armstrong, S.; Biddinger, P. W.; Miller, M. A.; Balakrishnan, K.; Wilson, K. M.; Saavedra, H. I. und Stambrook, P. J. (1998): Alloantigen gene therapy for squamous cell carcinoma of the head and neck: results of a phase-1 trial, Arch.Otolaryngol.Head Neck Surg. (Band 124), Nr. 10, Seite 1097-1104.

[149] Ramesh, R.; Saeki, T.; Templeton, N. S.; Ji, L.; Stephens, L. C.; Ito, I.; Wilson, D. R.; Wu, Z.; Branch, C. D.; Minna, J. D. und Roth, J. A. (2001): Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector, Mol.Ther (Band 3), Nr. 3, Seite 337-350.

[150] Sterman, D. H.; Molnar-Kimber, K.; Iyengar, T.; Chang, M.; Lanuti, M.; Amin, K. M.; Pierce, B. K.; Kang, E.; Treat, J.; Recio, A.; Litzky, L.; Wilson, J. M.; Kaiser, L. R. und Albelda, S. M. (2000): A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma, Cancer Gene Ther (Band 7), Nr. 12, Seite 1511-1518.

[151] Kirn, D.; Martuza, R. L. und Zwiebel, J. (2001): Replication-selective virotherapy for cancer: Biological principles, risk management and future directions.AB: , Nat.Med (Band 7), Nr. 7, Seite 781-787.

[152] Dettweiler, U. und Simon, P. (2001): Points to consider for ethics committees in human gene therapy trials, Bioethics. (Band 15), Nr. 5-6, Seite 491-500.

[153] Kovesdi, I.; Brough, D. E.; Bruder, J. T. und Wickham, T. J. (1997): Adenoviral vectors for gene transfer, Curr Opin Biotechnol. (Band 8), Nr. 5, Seite 583-589. URL: PM:0009353227

[154] Ritter, T.; Lehmann, M. und Volk, H. D. (2002): Improvements in gene therapy: averting the immune response to adenoviral vectors, BioDrugs. (Band 16), Nr. 1, Seite 3-10.

[155] Klimatcheva, E.; Rosenblatt, J. D. und Planelles, V. (1999): Lentiviral vectors and gene therapy, Front Biosci. (Band 4), Seite D481-D496. URL: PM:0010352135


[Seite 145↓]

[156] Robbins, R. D. und Ghivizzani, S. C. (1998): Viral vectors for gene therapy, Pharmacol.Ther. (Band 80), Seite 35-47.

[157] Schiedner, G.; Hertel, S.; Johnston, M.; Biermann, V.; Dries, V. und Kochanek, S. (2002): Variables affecting in vivo performance of high-capacity adenovirus vectors, Journal of Virology (Band 76), Nr. 4, Seite 1600-1609.

[158] Schiedner, G.; Morral, N.; Parks, R. J.; Wu, Y.; Koopmans, S. C.; Langston, C.; Graham, F. L.; Beaudet, A. L. und Kochanek, S. (1998): Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity, Nat.Genet. (Band 18), Nr. 2, Seite 180-183.

[159] Wilson, D. R. (2002): Viral-mediated gene transfer for cancer treatment, Curr.Pharm.Biotechnol. (Band 3), Nr. 2, Seite 151-164.

[160] Cemazar, M.; Sersa, G.; Wilson, J.; Tozer, G. M.; Hart, S. L.; Grosel, A. und Dachs, G. U. (2002): Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector, Cancer Gene Ther (Band 9), Nr. 4, Seite 399-406.

[161] Cowan, K. H.; Moscow, J. A.; Huang, H.; Zujewski, J. A.; O'Shaughnessy, J.; Sorrentino, B.; Hines, K.; Carter, C.; Schneider, E.; Cusack, G.; Noone, M.; Dunbar, C.; Steinberg, S.; Wilson, W.; Goldspiel, B.; Read, E. J.; Leitman, S. F.; McDonagh, K.; Chow, C.; Abati, A.; Chiang, Y.; Chang, Y. N.; Gottesman, M. M.; Pastan, I. und Nienhuis, A. (1999): Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients, Clin.Cancer Res. (Band 5), Nr. 7, Seite 1619-1628.

[162] Bruder, J. T. und Kovesdi, I. (1997): Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression, J Virol. (Band 71), Nr. 1, Seite 398-404. URL: PM:0008985363

[163] Fisher, K. D.; Stallwood, Y.; Green, N. K.; Ulbrich, K.; Mautner, V.; and Seymour, L. W. (2001): Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies

[164] DeMatteo, R. P.; McClane, S. J.; Fisher, K.; Yeh, H.; Chu, G.; Burke, C. und Raper, S. E. (1997): Engineering tissue-specific expression of a recombinant adenovirus: selective transgene transcription in the pancreas using the amylase promoter, Journal of Surgical Research (Band 72), Nr. 2, Seite 155-161.


[Seite 146↓]

[165] Jaffe, H. A.; Danel, C.; Longenecher, G.; Metzger, M.; Setoguchi, Y.; Rosenfeld, M. A.; Gant, T. W.; Thorgeirsson, S. S.; Stratford-Perricaudet, L. D. und Perricaudet, M. (1992): Adenovirus-mediated in vivo gene transfer and expression in normal rat liver, Nat.Genet. (Band 1), Nr. 5, Seite 372-378.

[166] Zwacka, R. M.; Zhou, W.; Zhang, Y.; Darby, C. J.; Dudus, L.; Halldorson, J.; Oberley, L. und Engelhardt, J. F. (1998): Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation., Nature Medicine (Band 4), Nr. 6, Seite 698-704. URL: PMID: 9623979, UI: 98285460

[167] Li, Q.; Bolli, R.; Qiu, Y.; Tang, X. L.; Murphree, S. S. und French, B. A. (1998): Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits, Circulation (Band 98), Nr. 14, Seite 1438-1448.

[168] Bilbao, G.; Contreras, J. L.; Gomez-Navarro, J.; Eckhoff, D. E.; Mikheeva, G.; Krasnykh, V.; Hynes, T.; Thomas, F. T.; Thomas, J. M. und Curiel, D. T. (1999): Genetic modification of liver grafts with an adenoviral vector encoding the BCL-2 gene improves organ preservation, Transplantation (Band 67), Seite 775-783.

[169] Graham, F. L. und Prevec, L. (1995): Methods for construction of adenovirus vectors, Mol.Biotechnol. (Band 3), Nr. 3, Seite 207-220. URL: PM:0007552690

[170] Sambrook, J.; Fritsch, E. F. und Maniatis, T. (1989): Molecular cloning: a laboratory manual, 2. Auflage , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.

[171] Lieber, C. S. und DeCarli, L. M. (1989): Liquid diet technique of ethanol administration: 1989 update, Alcohol and Alcoholism (Band 24), Seite 197-211.

[172] Lieber, C. S.; DeCarli, L. M. und Sorrell, M. F. (1989): Experimental models of ethanol administration., Hepatology (Band 10), Seite 501-510.

[173] Lieber, C. S. und DeCarli, L. M. (1994): Animal models of chronic ethanol toxicity, Methods Enzymol. (Band 233), Seite 585-594.

[174] Zhong, Z.; Connor, H. D.; Mason, R. P.; Lemasters, J. J. und Thurman, R. G. (1998): Ethanol, not fat accumulation per se, increases free radical production in a low-flow, reflow liver perfusion model, Transplantation (Band 66), Seite 1431-1438.

[175] Zhong, Z.; Connor, H.; Stachlewitz, R. F.; Frankenberg, M. v.; Mason, R. P.; Lemasters, J. J. und Thurman, R. G. (1997): Role of free radicals in primary non-function of marginal fatty grafts from rats treated acutely with ethanol., Molecular Pharmacology (Band 52), Seite 912-919.


[Seite 147↓]

[176] Zhong, Z.; Arteel, G. E.; Connor, H. D.; Schemmer, P.; Chou, S. C.; Raleigh, J. A.; Mason, R. P.; Lemasters, J. J. und Thurman, R. G. (1999): Binge drinking disturbs hepatic microcirculation after transplantation: prevention with free radical scavengers, Journal of Pharmacology and Experimental Therapeutics (Band 290), Nr. 2, Seite 611-620.

[177] Kamada, N. und Calne, R. Y. (1979): Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage, Transplantation (Band 28), Seite 47-50.

[178] Kamada, N. und Calne, R. Y. (1983): A surgical experience with five hundred thirty liver transplantations in the rat, Surgery (Band 93), Seite 64-69.

[179] Schemmer, P.; Schoonhoven, R.; Swenberg, J. A.; Bunzendahl, H. und Thurman, R. G. (1997): Gentle in situ liver manipulation during organ harvest decreases survival after rat liver transplantation: role of Kupffer cells, Transplantation (Band in press).

[180] McCord, J. M. und Fridovich, I. (1968): The reduction of cytochrome C by milk xanthine oxidase, The Journal of Biological Chemistry (Band 243), Seite 5753-5760.

[181] McCord, J. M. und Fridovich, I. (1970): The utility of superoxide dismutase in studying free radical reactions. II. The mechanism of the mediation of cytochrome c reduction by a variety of electron carriers., The Journal of Biological Chemistry (Band 245), Nr. 6, Seite 1374-1377.

[182] Ludde, T.; Kubicka, S.; Plumpe, J.; Liedtke, C.; Manns, M. P. und Trautwein, C. (2001): Ras adenoviruses modulate cyclin E protein expression and DNA synthesis after partial hepatectomy, Oncogene (Band 20), Nr. 38, Seite 5264-5278. URL: PM:11536040

[183] Enomoto, N.; Yamashina, S.; Schemmer, P.; Rivera, C. A.; Bradford, B. U.; Enomoto, A.; Brenner, D. A. und Thurman, R. G. (1999): Estriol sensitizes rat Kupffer cells via gut-derived endotoxin, American Journal of Physiology (Band 277), Nr. 3 Pt 1, Seite G671-G677.

[184] Iimuro, Y.; Nishiura, T.; Hellerbrand, C.; Behrns, K. E.; Schoonhoven, R.; Grisham, J. W. und Brenner, D. A. (1998): NFkappaB prevents apoptosis and liver dysfunction during liver regeneration, J Clin Invest (Band 101), Nr. 4, Seite 802-811.


[Seite 148↓]

[185] Savier, E.; Lemasters, J. J. und Thurman, R. G. (1994): Kupffer cells participate in rejection following liver transplantation in the rat, Transpl Int (Band 7), Seite S183-S186.

[186] Bergmeyer, H. U. (1988): Methods of enzymatic analysis, Academic Press, New York.

[187] Zabel, U.; Schreck, R. und Baeuerle, P. A. (1991): DNA binding of purified transcription factor NF-kB. Affinity, specificity, Zn2+ dependence, and differential half-site recognition, The Journal of Biological Chemistry (Band 266), Seite 252-260.

[188] Bradham, C. A.; Stachlewitz, R. F.; Gao, W.; Qian, T.; Jayadev, S.; Jenkins, G.; Hannun, Y. A.; Lemasters, J. J.; Thurman, R. G. und Brenner, D. (1997): Reperfusion after liver transplantation in rats differentially activates the mitogen activated protein kinases, Hepatology (Band 25), Seite 1128-1135.

[189] Schwabe, R. F.; Bennett, B. L.; Manning, A. M. und Brenner, D. A. (2001): Differential role of I kappa B kinase 1 and 2 in primary rat hepatocytes, Hepatology (Band 33), Nr. 1, Seite 81-90. URL: PM:11124824

[190] Chirgwin, J. M.; Przybyla, A. E.; MacDonald, R. J. und Rutter, W. J. (1979): Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry (Band 18), Seite 5294-5299.

[191] Mason, R. P. (1988): An introduction to electron resonance and its application to the study of free radical metabolites, Reactive oxygen species in chemistry, biology, and medicine , Plenum Press, New York.

[192] Lancaster, J. R.; Langrehr, J. M.; Bergonia, H. A.; Murase, N.; Simmons, R. L. und Hoffman, R. A. (1992): EPR Detection of Heme and Nonheme Iron-containing Protein Nitrosylation by Nitric Oxide during Rejection of Rat Heart Allograft, The Journal of Biological Chemistry (Band 267), Seite 10994-10998.

[193] Mason, R. P. (1984): Spin trapping free radical metabolites of toxic chemicals, Holtzman, J. L., Spin Labelling in Pharmacology , Seite 87-129, Academic Press, New York.

[194] Arroyo, C. M.; Kramer, J. H.; Leiboff, R. H.; Mergner, G. W.; Dickens, B. F. und Weglicki, W. B. (1987): Spin trapping of oxygen and carbon-centered free radicals in ischemic canine myocardium, Free radical biology & medicine (Band 3), Seite 313-316.


[Seite 149↓]

[195] Janzen, E. G.; Stronks, H. J.; DuBose, C. M.; Poyer, J. L. und McCay, P. B. (1985): Chemistry and biology of spin-trapping radicals associated with halocarbon metabolism in vitro and in vivo, Environmental Health Perspectives (Band 64), Seite 151-170.

[196] Nakazawa, H.; Arroyo, C. M.; Ichimori, K.; Saigusa, Y.; Minezaki, K. K. und Pronai, L. (1991): The demonstration of DMPO superoxide adduct upon reperfusion using a low non-toxic concentration, Free Radical Research Communications (Band 14), Seite 297-302.

[197] Connor, H. D.; Galizi, M. D.; Thurman, R. G.; and Mason, R. P. (1985): ESR studies of free radical metabolites in perfused livers

[198] Duling, D. R. (1994): Simulation on multiple isotropic spin-trap EPR spectra, J.Magnetic Resonance (Band 104), Seite 105-110.

[199] Lemasters, J. J. und Thurman, R. G. (1997): Reperfusion injury after liver preservation for transplantation., Annual Reviews in Pharmacology and Toxicology (Band 37), Seite 327-338.

[200] Bremer, C.; Bradford, B. U.; Hunt, K. J.; Knecht, K. T.; Connor, H. D.; Mason, R. P. und Thurman, R. G. (1994): Role of the Kupffer cell in the pathogenesis of hepatic reperfusion injury, American Journal of Physiology (Band 267), Seite G630-G636.

[201] Stachlewitz, R. F.; Gao, W.; Zhong, Z.; Connor, H. D.; Mason, R. P. und Thurman, R. G. (1998): Generation of lipid free radicals by adherent leukocytes from transplanted rat liver, Transpl.Int (Band 11), Nr. 5, Seite 353-360.

[202] Adkinson, D.; Höllwarth, M. E.; Benoit, J. N.; Parks, D. A.; McCord, J. M. und Granger, N. D. (1986): Role of free radicals in ischemia-reperfusion injury to the liver., Acta Physiol.Scand. (Band Suppl. 548), Seite 101-107.

[203] Connor, H. D.; Gao, W.; Nukina, S.; Lemasters, J. J.; Mason, R. P. und Thurman, R. G. (1992): Evidence that free radicals are involved in graft failure following orthotopic liver transplantation in the rat - an electron paramagnetic resonance spin trapping study, Transplantation (Band 54), Seite 199-204.

[204] Horie, Y.; Wolf, R.; Flores, S. C.; McCord, J. M.; Epstein, C. J. und Granger, D. N. (1998): Transgenic mice with increased copper/zinc-superoxide dismutase activity are resistant to hepatic leukostasis and capillary no-reflow after gut ischemia/reperfusion., Circ Res (Band 83), Nr. 7, Seite 691-696.


[Seite 150↓]

[205] Fujisawa, K; Saito, S.; Okada, Y; Fujiwara, T; Ota, K. und Tanaka, N. (1998): Possibility of gene transfer to the hepatic graft under cold preservation conditions, Transplant Proc (Band 30), Nr. 7, Seite 2911-2912.

[206] Zhong, Z.; Connor, H. D.; Mason, R. P.; Qu, W.; Gao, W.; Lemasters, J. J. und Thurman, R. G. (1995): Role of Kupffer cells in reperfusion injury in fat-loaded livers from ethanol-treated rats, Journal of Pharmacology and Experimental Therapeutics (Band 27), Seite 1512-1517.

[207] Bradham, C. A.; Schemmer, P.; Stachlewitz, R. F.; Thurman, R. G. und Brenner, D. A. (1999): Activation of nuclear factor-kappaB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells, Liver Transpl Surg (Band 5), Nr. 4, Seite 282-293. URL: PM:0010388501;http://www.ltsjournal.org/cgi/content/full/5/4/282;http://www.ltsjournal.org/cgi/content/abstract/5/4/282

[208] Li, N. und Karin, M. (1999): Is NF-kB the sensor of oxidative stress?, FASEB Journal (Band 13), Seite 1137-1143.

[209] Manna, S. K.; Zhang, H. J.; Yan, T.; Oberley, L. W. und Aggarwal, B. B. (1998): Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1, The Journal of Biological Chemistry (Band 273), Nr. 21, Seite 13245-13254. URL: PM:0009582369

[210] Kuhnel, F.; Zender, L.; Paul, Y.; Tietze, M. K.; Trautwein, C.; Manns, M. und Kubicka, S. (2000): NFkappaB Mediates Apoptosis through Transcriptional Activation of Fas (CD95) in Adenoviral Hepatitis, The Journal of Biological Chemistry (Band 275), Nr. 9, Seite 6421-6427. URL: PM:0010692445

[211] Verheij, M.; Bose, R.; Lin, X. H.; Yao, B.; Jarvis, W. D.; Grant, S.; Birrer, M. J.; Szabo, E.; Zon, L. I.; Kyriakis, J. M.; Haimovitz-Friedman, A.; Fuks, Z. und Kolesnick, R. N. (1996): Requirement for ceramide-initiated SAPK/JNK signalling in stress- induced apoptosis, Nature (Band 380), Nr. 6569, Seite 75-79. URL: PM:8598911

[212] Breen, A. P. und Murphy, J. A. (1995): Reactions of oxyl radicals with DNA, Free Radic.Biol Med (Band 18), Nr. 6, Seite 1033-1077. URL: PM:0007628729

[213] Wheeler, M. D.; Yamashina, S.; Froh, M.; Rusyn, I. und Thurman, R. G. (2001): Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-kappaB activation and cytokine production, J.Leukoc.Biol. (Band 69), Nr. 4, Seite 622-630. URL: PM:11310849


[Seite 151↓]

[214] Wheeler, M. D.; Katuna, M.; Smutney, O. M.; Froh, M.; Dikalova, A.; Mason, R. P.; Samulski, R. J. und Thurman, R. G. (2001): Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury, Hum.Gene Ther. (Band 12), Nr. 18, Seite 2167-2177. URL: PM:11779401

[215] Colletti, L. M.; Remick, D. G.; Burtch, G. D.; Kunkel, S. L.; Strieter, R. M. und Campbell, D. A. (1990): The role of tumor necrosis factor alpha in the pathophysiologic alterations follwoing hepatic ischemia/reperfusion injury, The Journal of Clinical Investigation (Band 85), Seite 1936-1943.

[216] Lowenthal, J. W.; Ballard, D. W.; Bogerd, H.; Bohnlein, E. und Greene, W. C. (1989): Tumor necrosis factor-alpha activation of the IL-2 receptor-alpha gene involves the induction of kappa B-specific DNA binding proteins, The Journal of Immunology (Band 142), Nr. 9, Seite 3121-3128. URL: PM:0002785134

[217] Marshall, E. (1999): Gene therapy death prompts review of adenovirus vector - [news], Scienc (Band 286), Nr. 5448, Seite 2244-2245. URL: PM:0010636774

[218] Muruve, D. A.; Barnes, M. J.; Stillman, I. E. und Liberman, T. A. (1999): Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo, Hum.Gene Ther. (Band 10), Seite 965-976.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
14.12.2004